Related Experiment Video
Updated: Mar 14, 2026
11:08
The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy
Published on: March 13, 2014
31.1K
Cholestasis of Pregnancy : A Prospective Study
Medical Journal, Armed Forces India
|October 1, 2016
Summary
Intrahepatic cholestasis of pregnancy (ICP) diagnosis may utilize alkaline phosphatase and aminotransferases if bile acids are unavailable. Ursodeoxycholic acid effectively alleviates ICP-related itching in pregnant individuals.
Area of Science:
- Obstetrics and Gynecology
- Hepatology
- Maternal-Fetal Medicine
Background:
- Intrahepatic cholestasis of pregnancy (ICP) is a late-gestation liver disorder.
- Elevated total bile acids (>11.0 µmol/L) are the primary diagnostic marker for ICP.
- While benign for the mother, ICP increases fetal morbidity and mortality risks.
Purpose of the Study:
- To evaluate diagnostic markers for ICP beyond bile acids.
- To assess the efficacy of ursodeoxycholic acid in managing ICP.
- To compare obstetric and fetal outcomes in ICP patients versus controls.
Main Methods:
- A prospective study of 1500 deliveries, including 27 ICP cases, was conducted.
- Exclusion criteria included other liver conditions; 300 controls underwent liver function tests.
- ICP patients received ursodeoxycholic acid treatment.
Main Results:
- ICP cases showed significantly elevated aminotransferases and alkaline phosphatase (p < 0.05).
- No significant differences in delivery mode or fetal outcomes were observed between ICP and control groups.
- Ursodeoxycholic acid significantly relieved pruritus (p < 0.01), but bilirubin and enzyme improvements were not statistically significant.
Conclusions:
- Alkaline phosphatase and aminotransferases may aid ICP diagnosis and management when bile acid levels are not available.
- Ursodeoxycholic acid demonstrates effectiveness in alleviating pruritus associated with ICP.
- ICP management should consider fetal well-being despite a benign maternal prognosis.
